BioSpace News Archive

Business

Imcyse Announces a Research Collaboration With Pfizer in Rheumatoid Arthritis (RA)

Under the terms of the agreement, Pfizer will provide an undisclosed amount to fund the research activities, and Pfizer has an exclusive option to negotiate a license agreement for a limited period following the research activities.

January 8, 2018
·
2 min read
VALBIOTIS Invited to Participate in Annual J.P. Morgan Healthcare Conference

In addition, VALBIOTIS is also participating in the Biotech Showcase, a satellite event focusing on biotechnology, which brings together more than 900 international industry investors in San Francisco from 8 to 10 January 2018.

January 8, 2018
·
2 min read
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures

Taiho Ventures joins the existing blue chip investor syndicate of Merck Ventures, Cambridge Innovation Capital, Pfizer Venture Investments and Touchstone Innovations with an equal size of investment.

January 8, 2018
·
1 min read
Biotech Bay

Agios Outlines Key 2018 Priorities Expanding Clinical and Research Programs to Drive Long Term Value

The presentation will outline how Agios’ clinical and research programs have the potential to provide meaningful benefit to a large number of patients.

January 8, 2018
·
10 min read
Business

IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year

Total revenue for the fourth quarter of 2017 expected to be $11.0 to $11.1 million.

January 8, 2018
·
2 min read
Drug Development

Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta Phase I Trial in Advanced Ovarian Cancer

Dosing expected to begin in 1Q18.

January 8, 2018
·
4 min read
Deals

Microbot Medical Enters Into Agreement to Acquire Novel Technology to Enhance Existing Technology Platforms and Strengthen Patent Portfolio

he acquisition is expected to close within 90 days, at which time, with the The addition of CadioSerts’ issued U.S. patent and three patent applications pending worldwide, Microbot would have a patent portfolio of 25 issued/allowed patents and 15 patent applications pending worldwide.

January 8, 2018
·
6 min read
Drug Development

Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Endpoints in Two Phase II Clinical Trials for Common Warts

Both trials evaluated the safety and efficacy of A-101 45% as compared to placebo (vehicle).

January 8, 2018
·
7 min read
Biotech Bay

Spirosure Raising $15M Series C-2 Financing to Expand Commercialization of Fenom PRO

The funds being raised will be used for sales and regulatory activities in Europe, China and Japan where the company is recruiting teams to commercialize its product.

January 8, 2018
·
5 min read
Business

Inovalon Expects Fourth Quarter Revenue Growth of 18% to 20% and Adjusted EBITDA Growth of 78% Assuming the Midpoint, Consistent with Prior Guidance

Fourth quarter revenue expected to be between $113.5 million to $115.0 million, up 18% to 20% year-over-year as reported and 13% to 15% year-over-year on an organic basis.

January 8, 2018
·
15 min read